NextCure (NXTC) stock: insider trades, news & valuation
Net buyingShare price and insider trades
NextCure insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $1.7M and 1 sold $185K of NXTC stock on the open market.
Get emailed when insiders cluster-buy stocks like NXTC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
NXTC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $1.7M | 13 | $185K | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 NextCure, Inc. insider reported open-market purchases totaling $1.7M, while 1 insider reported sales totaling $185K. Among insiders with enough purchase history to measure, Adar1 Capital Management, Llc (10% Owner) has the highest Insider Score at 67. 0 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 12SEC | Simcere Zaiming Pharmaceutical Co., Ltd. JiangsuFormer 10% Owner | Sell | 30,000308,636 held (−9%) | $6.16 | $185K | +16.6% | — |
| Aug 3SEC | Adar1 Capital Management, Llc10% Owner | Buy | 100,000608,266 held (+20%) | $4.90 | $490K | +46.5% | 67 |
| Aug 3SEC | Adar1 Capital Management, Llc10% Owner | Buy | 77,850686,116 held (+13%) | $4.96 | $386K | +44.8% | 67 |
| Aug 3SEC | Adar1 Capital Management, Llc10% Owner | Buy | 50,000443,266 held (+13%) | $4.97 | $248K | +44.5% | 67 |
| Aug 3SEC | Adar1 Capital Management, Llc10% Owner | Buy | 25,000714,416 held (+4%) | $4.98 | $124K | +44.2% | 67 |
| Aug 3SEC | Adar1 Capital Management, Llc10% Owner | Buy | 25,000508,266 held (+5%) | $4.81 | $120K | +49.3% | 67 |
| Aug 3SEC | Adar1 Capital Management, Llc10% Owner | Buy | 20,000463,266 held (+5%) | $5.00 | $100K | +43.6% | 67 |
| Aug 3SEC | Adar1 Capital Management, Llc10% Owner | Buy | 20,000483,266 held (+4%) | $5.00 | $100K | +43.6% | 67 |
| Aug 3SEC | Adar1 Capital Management, Llc10% Owner | Buy | 8,003722,419 held (+1%) | $4.80 | $38K | +49.6% | 67 |
| Aug 3SEC | Adar1 Capital Management, Llc10% Owner | Buy | 3,300689,416 held (+0%) | $4.98 | $16K | +44.2% | 67 |
| Jul 29SEC | Adar1 Capital Management, Llc10% Owner | Buy | 7,798383,456 held (+2%) | $5.00 | $39K | +43.6% | 67 |
| Jul 29SEC | Adar1 Capital Management, Llc10% Owner | Buy | 6,400389,856 held (+2%) | $4.95 | $32K | +45.1% | 67 |
| Jul 29SEC | Adar1 Capital Management, Llc10% Owner | Buy | 1,810391,666 held (+0%) | $5.00 | $9K | +43.6% | 67 |
| Jul 29SEC | Adar1 Capital Management, Llc10% Owner | Buy | 1,600393,266 held (+0%) | $5.00 | $8K | +43.6% | 67 |
Insiders at NextCure, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Adar1 Capital Management, Llc10% Owner | $1.7M | — | Aug 3, 2026 | 67 |
| Simcere Zaiming Pharmaceutical Co., Ltd. JiangsuFormer 10% Owner | — | $185K | Aug 12, 2026 | — |
NXTC stock: common questions
Are NextCure, Inc. insiders buying NXTC stock?
In the past 12 months, 1 insiders reported open-market purchases of NXTC worth $1.7M. The latest was 10% Owner Adar1 Capital Management, Llc bought $490K of NXTC at $4.90 — largest purchase by this insider in our records.
Are NextCure, Inc. insiders selling NXTC stock?
1 insiders reported sales worth $185K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is NXTC's 52-week range?
Over the past year NXTC has traded between $1.60 and $14.27. It last closed at $7.18 on Oct 9, 2026.